| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |